Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate efficacy of ethinylestradiol for intracyclic
bleeding profile in patients with dysmenorrhea and to investigate the long term safety
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Drospirenone Drospirenone and ethinyl estradiol combination Ethinyl Estradiol